The Nuclear Receptors FXR and LX alpha Potential Targets for the Development of Drugs Affecting Lipid Metabolism and Neoplastic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|4|231-259

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.4, 2001-03, pp. : 231-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear membrane receptors and channels as targets for drug development in cardiovascular diseases

By Bkaily Ghassan   Avedanian Levon   Jacques Danielle  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 2, 2009-02 ,pp. : 108-119

NRC Research Press

Access to resources Recommend Favorite

Nuclear Receptors CAR and PXR in Metabolism and Elimination of Drugs

By  

Current Pharmacogenomics, Vol. 1, Iss. 2, 2003-06 ,pp. : 75-85

Bentham Science Publishers

Access to resources Recommend Favorite

Orphan Nuclear Receptors as Targets for Drug Development

By Mukherjee Subhajit   Mani Sridhar  

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1439-1468

Springer Publishing Company

Access to resources Recommend Favorite

Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1227-1238

Bentham Science Publishers

Access to resources Recommend Favorite

Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases

By Lecci Alessandro   Maggi Carlo Alberto  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 3, 2003-06 ,pp. : 343-362

Informa Healthcare

Access to resources Recommend Favorite